Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Descriptive analysis of seizures and comorbidities associated with fragile X syndrome.
Albizua I, Charen K, Shubeck L, Talboy A, Berry-Kravis E, Kaufmann WE, Stallworth JL, Drazba KT, Erickson CA, Sweeney JA, Tartaglia N, Warren SF, Hagerman R, Sherman SL, Warren ST, Jin P, Allen EG. Albizua I, et al. Among authors: erickson ca. Mol Genet Genomic Med. 2022 Aug;10(8):e2001. doi: 10.1002/mgg3.2001. Epub 2022 Jul 18. Mol Genet Genomic Med. 2022. PMID: 35852003 Free PMC article.
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
Davenport MH, Schaefer TL, Friedmann KJ, Fitzpatrick SE, Erickson CA. Davenport MH, et al. Among authors: erickson ca. Drugs. 2016 Mar;76(4):431-45. doi: 10.1007/s40265-016-0542-y. Drugs. 2016. PMID: 26858239 Review.
Fragile X targeted pharmacotherapy: lessons learned and future directions.
Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E. Erickson CA, et al. J Neurodev Disord. 2017 Jun 12;9:7. doi: 10.1186/s11689-017-9186-9. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616096 Free PMC article. Review.
Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.
Budimirovic DB, Berry-Kravis E, Erickson CA, Hall SS, Hessl D, Reiss AL, King MK, Abbeduto L, Kaufmann WE. Budimirovic DB, et al. Among authors: erickson ca. J Neurodev Disord. 2017 Jun 12;9:14. doi: 10.1186/s11689-017-9193-x. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616097 Free PMC article. Review.
Eye gaze and pupillary response in Angelman syndrome.
Hong MP, Guilfoyle JL, Mooney LN, Wink LK, Pedapati EV, Shaffer RC, Sweeney JA, Erickson CA. Hong MP, et al. Among authors: erickson ca. Res Dev Disabil. 2017 Sep;68:88-94. doi: 10.1016/j.ridd.2017.06.011. Epub 2017 Jul 24. Res Dev Disabil. 2017. PMID: 28750207 Free PMC article.
Risperidone Treatment for Irritability in Fragile X Syndrome.
Dominick KC, Wink LK, Pedapati EV, Shaffer R, Sweeney JA, Erickson CA. Dominick KC, et al. Among authors: erickson ca. J Child Adolesc Psychopharmacol. 2018 May;28(4):274-278. doi: 10.1089/cap.2017.0057. Epub 2018 Feb 2. J Child Adolesc Psychopharmacol. 2018. PMID: 29394101
Best Practices in Fragile X Syndrome Treatment Development.
Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, Weber JD, Abbeduto L, Hessl D, Hagerman RJ, Berry-Kravis E. Erickson CA, et al. Brain Sci. 2018 Dec 15;8(12):224. doi: 10.3390/brainsci8120224. Brain Sci. 2018. PMID: 30558274 Free PMC article.
252 results